|
|
Mr. Hoogheem was most recently Chief Business and Financial Officer of ARCA Discovery, Inc., a BVIV portfolio company focused on developing and commercializing genetically-targeted therapies for heart failure and other cardiovascular diseases. Prior to joining ARCA, he was Executive Vice President, Finance and Operations and Chief Financial Officer of Dharmacon, Inc., another BVIV portfolio company. Dharmacon was sold to Fisher Scientific International Inc. in April 2004. Mr. Hoogheem also has held senior management positions at ChannelPoint, Inc., Somatogen, Inc., McData Corporation and Storage Technology Corporation. Mr. Hoogheem began his career at Price Waterhouse & Company. He is a graduate of University of Illinois at Urbana - Champaign. |